President, ZOLL Respicardia
Prior to being named President of ZOLL Respicardia in 2022, Collin spent four years as Vice President of Marketing and Market Access for Respicardia. In that role, he served as the commercial lead for marketing, reimbursement, medical education, physician training, and sales operations, and led the go-to-market strategy for Respicardia’s remedē System. Prior to joining Respicardia, Collin spent 15 years at Boston Scientific in a variety of leadership roles focused on global marketing, strategic and tactical planning, channel strategies, and product management. He holds an MBA from the Tuck School of Business at Dartmouth College, and a bachelor’s degree in engineering from North Dakota State University.
Robin Germany, M.D.
Chief Medical Officer
Dr. Robin Germany brings a wealth of respiratory and cardiovascular experience to Respicardia, where she serves as the Chief Medical Officer. Prior to joining Respicardia, she was the Director of Heart Failure Treatment and Medical Director of the Heart, Lung and Vascular Clinic at the University of Oklahoma. She followed her training in cardiovascular diseases at the University of Oklahoma with additional training in heart failure and electrophysiology. Her research focused on utilizing implantable devices to improve the care of heart failure patients. While serving as Chief Medical Officer for Respicardia, Dr. Germany retains her title of Clinical Assistant Professor at the University of Oklahoma.
Vice President, Quality Assurance/Regulatory Affairs
Kevin joined Respicardia in December of 2017. Kevin has over 30 years of experience developing, implementing, and improving quality management systems for both well-established and early-stage medical device companies. For the past 20 years, Kevin has held the top leadership roles in Regulatory and Quality where he has executed regulatory strategies across various types and classes of medical devices. Kevin holds a BS in Chemistry from the Rochester Institute of Technology and was RAC certified by the Regulatory Affairs Professional Society in 2004.
Vice President of Research and Development/Operations
Todd leads the R&D and operations efforts at Respicardia, bringing extensive experience in implantable and neurostimulation medical technologies. His prior experience includes VP of R&D at Pulmonetic Systems whose product successes led to their acquisition by Viasys Healthcare, followed by Cardinal Health. Prior to Pulmonetic Systems, Todd held various engineering management positions over nine years with the Cardiac Rhythm Management and Neurological Divisions of Medtronic. He holds a B.S. in Electrical Engineering from Marquette University and an M.S. in Computer Engineering from National Technological University.
Frank Piskolich, J.D
Frank has more than sixteen years of legal experience in the medical device industry preceded by eleven years in engineering and leadership. Frank is responsible for all legal functions within Respicardia, including risk management, intellectual property and disputes. Prior to joining Respicardia Frank represented a range of clients while practicing law at Fredrikson and Byron, P.A. and is licensed to practice before the United States Patent and Trademark Office and the federal and state courts of Minnesota. Frank holds a Bachelor of Science degree in Chemical Engineering from Rose-Hulman Institute of Technology and a Juris Doctorate from the University of Minnesota Law School where he graduated cum laude and was a managing editor on the Minnesota Law Review.
Director of Human Resources
Stephanie leads the Human Resources efforts at Respicardia. She brings 15 years’ experience in a variety of HR functions including employee relations and development, adult learning, talent management, benefit administration, and leadership training and development. Stephanie received a Bachelor of Arts degree from the University of Minnesota, Morris and a Master’s of Education degree in Human Resources Development from the University of Minnesota, Twin Cities. She also holds PHR and SHRM-CP certifications.
Director of Finance
Andy leads the Finance and Administration efforts at Respicardia. He brings 20 years of accounting and finance experience to Respicardia. He has been in the medical device industry for nearly 15 years with ZOLL Medical Corporation and Advanced Circulatory Systems, Inc. Previously, Andy worked for the accounting firm Baker Tilly, where he worked with a number of client companies across a range of industries. Andy holds a Bachelor of Science degree in Accounting from Minnesota State University, Mankato. He earned his CPA license in 2006 and Certified Professional Project Manager certification in 2020.